Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
- Resource Type
- article
- Source
- Frontiers in Oncology, Vol 12 (2022)
- Subject
BTLA butyrophilins serum CA125 circulating immune checkpoints HGSOC PD-1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 2234-943X